High EFNA5 expression is associated with lower OS in ovarian carcinoma [71] and pancreatic cancer [47] but associated with a better prognosis in prostate cancer [17], hepatoma [49], and glioblastoma [18]. This evidence concerns the gene EFNA5 and prostate carcinoma.